Xiguang Liu Yating Zheng Shijie Mai Yu Tong Lili Yang Mengli Huang Ruijun Cai
10.3389/fonc.2022.1033322
Front Oncol
2022 Nov 25;12:1033322.
egfr chemotherapy neoadjuvant osimertinib pulmonary sarcomatoid carcinoma
CC BY
https://pubmed.ncbi.nlm.nih.gov/36505870/
Case Reports
PMC9733669
36505870
Case report: an initially unresectable stage III pulmonary sarcomatoid carcinoma qith EGFR mutation achieving pathological complete response following neoadjuvant therapy with osimertinib plus chemotherapy
2022